Domestic market for flexible endoscopes

According to statistics,In 2020, the size of China's endoscope market reached 25.4 billion RMB, with a compound annual growth rate of approximately 14.2% from 2015 to 2020. During the same period, the global endoscope market size increased from US\$16.4 billion to US\$21.5 billion, with a compound annual growth rate of 5.5%.The growth rate of the Chinese market is much faster than the global average, and its share of the global market is constantly increasing.

Currently, the market concentration of China's flexible endoscope industry is high, with Olympus, Pentax, Fujifilm, AUWA Medical, and KL dominate the major market share, especially in the high-end field, where two Japanese multinational companies, Olympus and Fujifilm, are almost in a monopoly position.On the one hand, domestic flexible endoscope companies still have a certain gap in product performance compared with multinational companies. On the other hand, foreign flexible endoscope Brands have been developing for a longer time and have better market adhesion, resulting in a certain degree of import dependence on imported flexible endoscopes in China.

Currently, the flexible endoscope market has significant potential development opportunities and huge demand space,The main players in the domestic flexible endoscope market include Olympus, Fujifilm, Pentax, KL, AUWA, XION, and E&E. Let's briefly introduce them below.

 Olympus

Established in 1919, the company holds a dominant position in the flexible endoscope field. In the field of endoscopy, Olympus's main endoscope products currently include digestive endoscopes, biliary endoscopes, laparoscopes, electronic gastroscopes, cystoscopes, ureteroscopes, percutaneous nephroscopes, hysteroscopes, colposcopes, bronchoscopes, and otolaryngoscopes, etc.Previously developed a new system called EVIS LUCERA ELITE. EVIS LUCERA ELITE is designed to provide higher imaging performance and easier use for physicians performing colonoscopies, featuring many new technologies and innovations.

Fujifilm

 Established in 1934, its main businesses include imaging solutions, information solutions, and document solutions. The medical business is one of Fujifilm's main businesses.Fujifilm's endoscope product series mainly covers digestive endoscopes and systems, respiratory bronchoscopy systems, ultrasonic bronchoscopy systems, and otolaryngology electronic endoscopy systems, etc. During the China County Health Conference,Fujifilm launched the new ELUXEO Lite 6000, a cost-effective new generation endoscope system.

The system is equipped with Fujifilm's exclusive LCI linked imaging technology and BLI blue light imaging technology, which increases the contrast of mucosal color and the recognition of surface structure, thus significantly improving the detection rate of early cancer lesions, achieving accurate screening with high cost-effectiveness, and serving the county-level early cancer screening work.

Pentax

Pentax is a branch of the Japanese HOYA Group, acquired by HOYA Corporation in 2007, and is committed to endoscope imaging solutions. It is a global diversified company with research and development and manufacturing centers in Japan, Europe, and the United States.The medical endoscope business is a growth business within HOYA's global business. The demand for minimally invasive treatment in medical professions is growing rapidly. Relying on the Pentax medical Brand, HOYA develops medical endoscopes to assist in early treatment and diagnosis.

 XION

 XION's ultra-high-definition electronic nasal and laryngoscope examination system and nasal endoscope surgery system use full digital processing and transmission, with high-quality optical advantages, providing high-definition, large-screen images. The realistic color reproduction and mucosal presentation obtained through the digital camera image acquisition method make it easier to observe the patient's subtle lesions.It is the world's only multi-functional diagnostic and treatment system for otorhinolaryngology, and also the world's only system that can simultaneously support the use of electronic flexible endoscopes and ordinary rigid endoscopes.

AUWA Medical

 Established in 1994, it is one of the earliest companies in China to engage in the research and development and manufacturing of flexible electronic endoscopes. After nearly 30 years of focus and innovation, AUWA Medical has broken through key technologies in endoscopes and has carried out systematic product layout around the field of endoscopic diagnosis and treatment.In 2005, AUWA Medical launched its first-generation electronic endoscope system, VME-2000—one of the earliest domestically produced flexible electronic endoscopes in China,Its appearance also broke the situation where flexible electronic endoscopes were completely dependent on imported equipment.AUWA Medical launched the AQ-200 full HD light-transmitting endoscope system. This product innovatively uses laser transmission technology to transmit 1080P image information.Laser transmission, compared with electrical signal transmission, is not affected by electromagnetic interference, making it easier to combine with high-frequency electrosurgical knives and other peripheral equipment under the endoscope, which can improve the safety and convenience of clinical operation.

KL

 Established in 2002, its main products are ultrasound diagnostic systems, electronic endoscope systems, and in-vitro diagnostic series. It was listed on the Shenzhen Stock Exchange's ChiNext board in 2017. Since entering the endoscope field in 2012, in less than 10 years of development, KL has risen from an industry newcomer to the world's advanced level.

Last September, the ultrasonic electronic upper gastrointestinal endoscope EG-UR5 successfully obtained NMPA approval.EG-UR5 is mainly used for endoscopic observation and diagnosis of the upper gastrointestinal tract lumen, and simultaneously performs ultrasound scanning of the upper gastrointestinal wall and surrounding organs. It has extremely high value in the localization and qualitative diagnosis of benign and malignant lesions in the esophagus, mediastinum, stomach, duodenum, pancreatobiliary system, and adrenal glands, etc.

 Inmedar

Inmedar was established in 2015. It is a national high-tech enterprise dedicated to providing original minimally invasive medical devices for the diagnosis and treatment of major diseases (such as cancer and cardiovascular and cerebrovascular diseases).The company currently focuses on minimally invasive interventional devices in the cardiovascular and digestive systems, especially the development of intravascular interventional imaging products. The company's three core products are ultrasound endoscopes, electronic endoscopes, and vascular imaging systems.

On December 27, 2021, Inmedar, a domestic endoscope manufacturer, officially obtained approval from the Guangdong Provincial Drug Supervision and Administration Bureau for its independently developed full-HD electronic endoscope for the digestive tract.The approved full-HD electronic endoscope for the digestive tract has reached internationally leading levels in terms of technology, with complete functions. It can provide more reliable evidence for clinical diagnosis and treatment and is an important means of screening for early digestive tumors.

In general, the development of domestic endoscopes is progressing smoothly, with continuous strengthening of research and development innovation, continuous introduction of new products, and catching up with foreign manufacturers in many aspects.Under the domestic tiered medical treatment and encouragement of domestic substitution policies, domestic Brands are expected to surpass imported Brands in the primary medical market with higher cost performance.

This information is from the internet. Please contact us for deletion if there is any infringement.